Cryptogenic cirrhosis in the region where obesity is not prevalent (Q33867312)

29 July 2017

Cryptogenic cirrhosis in the region where obesity is not prevalent (English)

1 reference

29 July 2017

0 references

Hideyuki Kojima

1

1 reference

29 July 2017

Shinya Sakurai

2

1 reference

29 July 2017

Masahiko Matsumura

3

1 reference

29 July 2017

Norie Umemoto

4

1 reference

29 July 2017

Masahito Uemura

5

1 reference

29 July 2017

Hiroyo Morimoto

6

1 reference

29 July 2017

Yasuhiro Tamagawa

7

1 reference

29 July 2017

Hiroshi Fukui

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

World Journal of Gastroenterology

29 July 2017

1 reference

29 July 2017

12

1 reference

29 July 2017

13

1 reference

29 July 2017

2080-2085

1 reference

Prevalence and Trends in Obesity Among US Adults, 1999-2000

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Liver fibrosis in overweight patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Tamoxifen-induced fatty liver in patients with breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I13.2080

New criteria for 'obesity disease' in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I13.2080

Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I13.2080

Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I13.2080

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I13.2080

Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Liver damage in obese patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

The continuing epidemics of obesity and diabetes in the United States

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087689

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

29 October 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I13.2080

Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation

21 January 2018

1 reference

12 December 2020

A novel technique for the determination of body fat by computed tomography

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I13.2080

1 reference

29 July 2017

1 reference

29 July 2017

1 reference